ARTICLE | Clinical News
AT7519: Phase II started
August 23, 2010 7:00 AM UTC
Astex began an open-label, U.S. Phase II trial to evaluate intravenous AT7519 alone or with Velcade bortezomib in up to 30 patients. Millennium Pharmaceuticals Inc., a subsidiary of Takeda Pharmace...